NCT05507892: Renal Mechanism of SGLT2 Inhibition
- State
- Under way
- Phase
- Phase 2
- People
- 45 taking part
- Started
- 10 Oct 2022
- Primary completion
- 15 Dec 2026
- Arms
- Treatment
- Results
- None posted
- 19 Aug 2022: Trial registered
- 10 Oct 2022: Trial started
A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set
Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.
Registries searched: ClinicalTrials.gov, through 17 Nov 2026.